Cutting Edge Technology and Clinical Research Trials

AMD & Diabetic Retinopathy

The physicians and staff at the National Retina Institute (NRI) are committed to providing patients with an exceptionally broad range of treatment options in our belief that each individual requires personalization of his or her care.

In pursuit of this goal, NRI continually brings together the most advanced, cutting-edge technology with participation in FDA Clinical Trials for treatment of retinal disorders including Macular Degeneration, Diabetic Retinopathy, and Retinal Vein Occlusions.